Some cookies are essential to the running of the website, while others (analytics) help us to make improvements. We also incorporate functionality from other websites, such as video, social media feeds and ReachDeck (text-to-speech and translations services) which may set cookies. More on how we use cookies
This website uses text-to-speech software called ReachDeck to read and / or translate its content. To use ReachDeck, you must allow ReachDeck cookies; the ReachDeck icon will then appear at the bottom of your screen.
You can find out more about how ReachDeck uses cookies or change your cookie preferences at any time by going to our cookies page.
Allow ReachDeck cookies Do not use ReachDeck
This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.
In clinical immunology, we offer two assays to detect latent TB infection:
Both of these assays measure the Interferon-gamma response to TB specific antigens [ESAT-6 and CFP10 and TB7.1 for quantiferon] and are therefore often known as Interferon Gamma Release Assays (IGRAs). They are specific to latent TB infection and not affected by BCG vaccination.
Please note these assays cannot be used to distinguish between latent and active TB infection.